Trial Profile
Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2022
Price :
$35
*
At a glance
- Drugs Interferon alpha-2a (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 20 May 2014 New trial record